Octreotide and hypovolaemia Patient Reports February 12, 2012

Octreotide Side Effects Report #5897728-3
Octreotide side effect was reported by a Health Professional from JAPAN on Sept 17, 2008. Female patient, child 9 years of age, was diagnosed with pancreatitis, acute lymphocytic leukaemia and was treated with Octreotide. After drug was administered, patient experienced the following side effects: abdominal pain , blood amylase increased, c-reactive protein increased, hypovolaemia, oliguria. Octreotide dosage: unknown. During the same period patient was treated with ANTINEOPLASTIC AGENTS. Patient recovered.

Octreotide Side Effects Report #6017423-X
Octreotide side effect was reported by a Health Professional from JAPAN on Dec 18, 2008. Female patient, child 9 years of age, was diagnosed with pancreatitis, acute lymphocytic leukaemia and was treated with Octreotide. After drug was administered, patient experienced the following side effects: abdominal pain , blood amylase increased, c-reactive protein increased, hypovolaemia, oliguria, pancreatitis acute. Octreotide dosage: unknown. During the same period patient was treated with ANTINEOPLASTIC AGENTS. Patient recovered.

Octreotide Side Effects Report #5897743-X
Octreotide side effect was reported by a Health Professional from JAPAN on Sept 17, 2008. Male patient, child 7 years of age, was diagnosed with pancreatitis, acute lymphocytic leukaemia and was treated with Octreotide. After drug was administered, patient experienced the following side effects: abdominal pain , blood amylase increased, c-reactive protein increased, hypovolaemia, oliguria, pancreatic pseudocyst. Octreotide dosage: unknown. During the same period patient was treated with ANTINEOPLASTIC AGENTS. Patient recovered.

Octreotide Side Effects Report #6021585-8
Octreotide side effect was reported by a Health Professional from JAPAN on Dec 18, 2008. Male patient, child 7 years of age, was diagnosed with pancreatitis, acute lymphocytic leukaemia and was treated with Octreotide. After drug was administered, patient experienced the following side effects: abdominal pain , blood amylase increased, c-reactive protein increased, hypovolaemia, oliguria, pancreatic pseudocyst, pancreatitis acute. Octreotide dosage: unknown. During the same period patient was treated with ANTINEOPLASTIC AGENTS. Patient recovered.